Effect of Pumpkin Seed Oil or Pumpkin Seeds on Blood Pressure and Menopausal Symptoms in Postmenopausal Women
Effect of Supplementation With Pumpkin Seed Oil Versus Pumpkin Seeds on Blood Pressure and Menopausal Symptoms in Non-hypertensive Postmenopausal Women
1 other identifier
interventional
27
1 country
1
Brief Summary
The purpose of this randomized control trial is to compare the effect of pumpkin seed oil 2g/day with pumpkin seeds given as a dose of 1½ teaspoons/ 4.1 grams a day to provide 2g of lipid (equivalent to 2 grams of oil) on BP (systolic and diastolic), endothelial function, serum lipids, C-reactive protein (CRP) concentrations, and menopausal symptoms in postmenopausal women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Aug 2015
Typical duration for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 21, 2016
CompletedFirst Posted
Study publicly available on registry
April 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 10, 2017
CompletedMay 3, 2018
May 1, 2018
1.9 years
March 21, 2016
May 2, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in systolic and diastolic blood pressure
change measured - baseline and 12 weeks
Secondary Outcomes (6)
Change in Total Cholesterol level (mg/dl)
change measured - baseline and 12 weeks
Change in Plasma Triglycerides (mg/dl)
change measured - baseline and 12 weeks
Change in Plasma High-Density Lipoprotein Cholesterol (mg/dl)
change measured - baseline and 12 weeks
Change in Plasma Low-Density Lipoprotein Cholesterol (mg/dl)
change measured - baseline and 12 weeks
Change in C-reactive protein (CRP)
change measured - baseline and 12 weeks
- +1 more secondary outcomes
Study Arms (2)
Pumpkin seed oil
EXPERIMENTALPumpkin seed oil (1g) capsules - 2 capsules per day for 12 weeks
Pumpkin seeds
ACTIVE COMPARATORPacket of pumpkin seeds (4.1 grams /\~0.15ounces) - 1 pack per day for 12 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Non-hypertensive with blood pressure less than140/90 mmHg
- Post menopausal women or had a bilateral oophorectomy
You may not qualify if:
- Hypotensive women with BP \<90/60
- Taking medications to manage blood pressure and blood lipids
- Taking estrogen supplements or on hormone replacement therapy
- Taking pumpkin seed oil supplements
- Consuming pumpkin seeds more than ¼ cup a month
- Diagnosed with depression and taking antidepressants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Texas Woman's University
Houston, Texas, 77030, United States
Related Publications (2)
Gossell-Williams M, Lyttle K, Clarke T, Gardner M, Simon O. Supplementation with pumpkin seed oil improves plasma lipid profile and cardiovascular outcomes of female non-ovariectomized and ovariectomized Sprague-Dawley rats. Phytother Res. 2008 Jul;22(7):873-7. doi: 10.1002/ptr.2381.
PMID: 18567058RESULTGossell-Williams M, Hyde C, Hunter T, Simms-Stewart D, Fletcher H, McGrowder D, Walters CA. Improvement in HDL cholesterol in postmenopausal women supplemented with pumpkin seed oil: pilot study. Climacteric. 2011 Oct;14(5):558-64. doi: 10.3109/13697137.2011.563882. Epub 2011 May 5.
PMID: 21545273RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Madhura Maiya, MS
Texas Woman's University
- STUDY CHAIR
Carolyn Moore, PhD
Texas Woman's University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2016
First Posted
April 4, 2016
Study Start
August 1, 2015
Primary Completion
June 16, 2017
Study Completion
November 10, 2017
Last Updated
May 3, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share